Fmr LLC Chroma Dex Corp. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Fmr LLC holds 17,691 shares of CDXC stock, worth $108,622. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,691

Previous 15,890 11.33%

Holding current value

$108,622

Previous $109,000 0.92%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$5.42 - $7.08 $9,761 - $12,751	1,801 Added 11.33%	17,691 $108,000
Q1 2025 May 12, 2025	BUY	$5.26 - $8.55 $5,423 - $8,815	1,031 Added 6.94%	15,890 $109,000
Q4 2024 Feb 13, 2025	SELL	$3.25 - $7.72 $958 - $2,277	-295 Reduced 1.95%	14,859 $78,000
Q3 2024 Nov 13, 2024	BUY	$2.51 - $3.8 $38,036 - $57,585	15,154 New	15,154 $55,000
Q3 2023 Nov 13, 2023	SELL	$1.36 - $1.77 $13 - $17	-10 Reduced 35.71%	18 $0
Q2 2023 Aug 11, 2023	SELL	$1.31 - $1.79 $14 - $19	-11 Reduced 28.21%	28 $0
Q1 2023 May 11, 2023	BUY	$1.48 - $2.19 $11 - $17	8 Added 25.81%	39 $0
Q4 2022 Feb 13, 2023	BUY	$1.25 - $1.94 $23 - $36	19 Added 158.33%	31 $0
Q3 2022 Nov 10, 2022	SELL	$1.19 - $2.06 $13,792 - $23,875	-11,590 Reduced 99.9%	12 $0
Q2 2022 Aug 12, 2022	BUY	$1.59 - $2.7 $9,582 - $16,272	6,027 Added 108.11%	11,602 $19,000
Q1 2022 May 13, 2022	BUY	$2.02 - $3.92 $11,202 - $21,740	5,546 Added 19124.14%	5,575 $14,000
Q4 2021 Feb 14, 2022	SELL	$3.74 - $6.7 $2,401 - $4,301	-642 Reduced 95.68%	29 $0
Q2 2021 Aug 13, 2021	BUY	$6.66 - $10.92 $4,468 - $7,327	671 New	671 $6,000

Others Institutions Holding CDXC

# of Institutions

168

Shares Held

27.9M

Call Options Held

143K

Put Options Held

189K

View Full List

About ChromaDex Corp.

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $420M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

More about CDXC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account